Global Antifungal Drugs Market 2017-2021
SKU ID :TNV-10355576 | Published Date: 10-Feb-2017 | No. of pages: 91Description
TOC
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
Five forces analysis
PART 06: Market segmentation by ROA
Global oral antifungal drugs market
Global parenteral antifungal drugs market
Global topical antifungal drugs market
PART 07: Market segmentation by type
Global prescription antifungal drugs market
Global OTC antifungal drugs market
PART 08: Market segmentation by chemical class
PART 09: Geographical segmentation
Antifungal drugs market in Americas
Antifungal drugs market in the US
Antifungal drugs market in EMEA
Antifungal drugs market in Europe
Antifungal drugs market in APAC
Antifungal drugs market in Japan
PART 10: Market drivers
QIDP and other special regulatory designations
Increase in prevalence of infections and environmental changes
Rising popularity of OTC antifungal drugs for dermal infections
PART 11: Impact of drivers
PART 12: Market challenges
Antifungal drug resistance
Increased availability of generics and alternative therapies
Poor patient adherence
PART 13: Impact of drivers and challenges
PART 14: Market trends
Increased funding for antifungal research
Increased focus on combination therapies
Incorporation of novel technology for product development
Strategic alliances and M&A
PART 15: Vendor landscape
Competitive scenario
Other prominent vendors
PART 16: Key vendor analysis
Astellas Pharma
Johnson & Johnson
Merck
Novartis
Pfizer
PART 17: Appendix
List of abbreviations
PART 18: Explore Technavio
List of Exhibits
Exhibit 01: Market snapshot of global antifungal drugs market
Exhibit 02: Overview of global antifungal drugs market 2016-2021
Exhibit 03: Global antifungal drugs market snapshot: Developed and emerging markets 2016-2021
Exhibit 04: Global antifungal drugs market 2016-2021 ($ billions)
Exhibit 05: Opportunity analysis in global antifungal drugs market
Exhibit 06: Impact of factors affecting the market 2016 and 2021
Exhibit 07: Impact of key customer segments on global antifungal drugs market 2016
Exhibit 08: Five forces analysis
Exhibit 09: Share of global antifungal drugs by ROA 2016 and 2021
Exhibit 10: Market overview of global oral antifungal drugs market
Exhibit 11: Market overview of global parenteral antifungal drugs market
Exhibit 12: Market overview of global topical antifungal drugs market
Exhibit 13: Global antifungal drugs market segmentation by type 2016
Exhibit 14: Market overview of global prescription antifungal drugs market
Exhibit 15: Market overview of global OTC antifungal drugs market
Exhibit 16: Types of anti-fungal drugs by chemical class
Exhibit 17: Global antifungal drugs market: Segmentation by geography (2016-2021)
Exhibit 18: Global antifungal drugs market segmentation by region: Market growth lifecycle analysis 2016
Exhibit 19: Overview of antifungal drugs market in Americas
Exhibit 20: Antifungal drugs market in Americas 2016-2021 ($ billions)
Exhibit 21: Opportunity analysis in antifungal drugs market in Americas
Exhibit 22: Overview of antifungal drugs market in the US
Exhibit 23: Overview of antifungal drugs market in EMEA
Exhibit 24: Antifungal drugs market in EMEA 2016-2021 ($ billions)
Exhibit 25: Opportunity analysis in antifungal drugs market in EMEA
Exhibit 26: Overview of antifungal drugs market in Europe
Exhibit 27: Overview of antifungal drugs market in APAC
Exhibit 28: Antifungal drugs market in APAC 2016-2021 ($ billions)
Exhibit 29: Opportunity analysis in antifungal drugs market in APAC
Exhibit 30: Overview of antifungal drugs market in Japan
Exhibit 31: Impact of drivers and challenges on global antifungal drugs market
Exhibit 32: Impact of drivers
Exhibit 33: Impact of drivers and challenges
Exhibit 34: Impact of trends in global antifungal drugs market
Exhibit 35: Competitive structure analysis of global antifungal drugs market 2016
Exhibit 36: Competitive analysis of global antifungal drugs market
Exhibit 37: Market penetration of various antifungal drug makers worldwide 2016
Exhibit 38: Astellas Pharma: Key highlights
Exhibit 39: Astellas Pharma: Strength assessment
Exhibit 40: Astellas Pharma: Strategy assessment
Exhibit 41: Astellas Pharma: Opportunity assessment
Exhibit 42: Johnson & Johnson: Key highlights
Exhibit 43: Johnson & Johnson: Strength assessment
Exhibit 44: Johnson & Johnson: Strategy assessment
Exhibit 45: Johnson & Johnson: Opportunity assessment
Exhibit 46: Merck: Key highlights
Exhibit 47: Merck: Strength assessment
Exhibit 48: Merck: Strategy assessment
Exhibit 49: Merck: Opportunity assessment
Exhibit 50: Novartis: Key highlights
Exhibit 51: Novartis: Strength assessment
Exhibit 52: Novartis: Strategy assessment
Exhibit 53: Novartis: Opportunity assessment
Exhibit 54: Pfizer: Key highlights
Exhibit 55: Pfizer: Strength assessment
Exhibit 56: Pfizer: Strategy assessment
Exhibit 57: Pfizer: Opportunity assessment
Tables & Figures
Companies
Pfizer, Merck, Astellas Pharma, Novartis, Johnson & Johnson, Allergan, Almirall, Amgen, Aqua Pharmaceuticals, AstraZeneca, Bayer, Bristol-Myers Squibb, Celgene, Dermira, Elorac, F. Hoffmann-La Roche, Galderma, Genentech, GlaxoSmithKline, Hexima, Hisamitsu Pharmaceutical, Incyte, Mayne Pharma, MediQuest Therapeutics, Meiji Seika Pharma, Merz Pharmaceuticals, Moberg Pharma, Mylan Pharmaceuticals, NanoBio, NovaBiotics, Novan, Nuvo Research, Polichem, Promius Pharma, Sanofi, Seren Pharmaceuticals, Sun Pharma, Taro, Teva Pharmaceutical, Theravance Biopharma, Topica Pharmaceuticals, Viamet Pharmaceuticals.
- PRICE
-
$2500$4000